The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient perceptions about their treatment for muscle-invasive bladder cancer (MIBC) over the last decade.
 
Deepro Chowdhury
No Relationships to Disclose
 
Andrea Apolo
No Relationships to Disclose
 
Di Maria Jiang
Honoraria - Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; Bayer; Bayer; Bayer; Bayer; EMD Serono; Ipsen; Janssen Oncology; Janssen Oncology; Janssen Oncology; Janssen Oncology; Medunik; Novartis AAA
Consulting or Advisory Role - AstraZeneca/Merck; Bayer; Janssen Oncology; McKesson; Merck; Novartis AAA; Pfizer; Pfizer/EMD Serono; Pfizer/EMD Serono; Pfizer/EMD Serono; Seagen
Research Funding - Amgen; Astellas Pharma (Inst); Bayer; Pfizer; Tersera
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; EMD Serono; EMD Serono; Pfizer; Pfizer; Pfizer; Pfizer; Roche
 
Eila Skinner
Research Funding - Pfizer/Seagen
 
Stephanie Chisolm
No Relationships to Disclose
 
Rick Bangs
Honoraria - Gilead Sciences
Consulting or Advisory Role - Gilead Sciences; Nonagen Bioscience
Travel, Accommodations, Expenses - Gilead Sciences
Other Relationship - Bladder Cancer Advocacy Network; National Cancer Institute; SWOG; SWOG; SWOG
(OPTIONAL) Uncompensated Relationships - Genentech; Gilead Sciences
 
Manjula Maganti
No Relationships to Disclose
 
Gary Steinberg
Stock and Other Ownership Interests - CG Oncology; enGene; Epivax Therapeutics
Honoraria - Aduro Biotech; AstraZeneca; Bristol-Myers Squibb; CG Oncology; enGene; Epivax Oncology; fergene; Ferring; Fidia Farmaceutici S. p. A.; FKD Therapies; Janssen Oncology; MDxHealth; Merck; Pfizer; Photocure; Roche/Genentech; Seagen; Sesen Bio; Urogen pharma
Consulting or Advisory Role - Asieris Pharmaceuticals; AstraZeneca; Aura Biosciences; Boston Scientific; CG Oncology; Fidia Farmaceutici S. p. A.; Heat Biologics; Imvax; MDxHealth; Merck; NanOlogy; Natera; Nonagen Bioscience; photocure; Roche/Genentech; Taris BioMedical; Verity Pharmaceuticals
 
Matthew Kaag
No Relationships to Disclose
 
Jason Efstathiou
Honoraria - Elekta; IBA
Consulting or Advisory Role - AngioDynamics; AstraZeneca; Bayer; Blue Earth Diagnostics; Blue Earth Diagnostics; Boston Scientific; Genentech; Gilead Sciences; Janssen; Lantheus Medical Imaging; Merck; Myovant Sciences; Pfizer; Progenics
 
Srikala Sridhar
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Gilead Sciences (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
Research Funding - Bayer (Inst); Janssen (Inst); Pfizer (Inst)